These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14529348)

  • 1. Modified envelope glycoproteins to retarget retroviral vectors.
    Haynes C; Erlwein O; Schnierle BS
    Curr Gene Ther; 2003 Oct; 3(5):405-10. PubMed ID: 14529348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modifying the host range properties of retroviral vectors.
    Russell SJ; Cosset FL
    J Gene Med; 1999; 1(5):300-11. PubMed ID: 10738547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification of retrovirus particles using heparin affinity chromatography.
    Segura MM; Kamen A; Garnier A
    Methods Mol Biol; 2008; 434():1-11. PubMed ID: 18470635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of transduction-competent retroviral vectors by infection with a single hybrid vaccinia virus.
    Konetschny C; Holzer GW; Urban C; Hämmerle T; Mayrhofer J; Falkner FG
    J Virol; 2003 Jun; 77(12):7017-25. PubMed ID: 12768020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of retroviral packaging and producer cell lines for large-scale vector production with improved safety and titer.
    Dubensky TW; Sauter SL
    Methods Mol Med; 2003; 76():309-30. PubMed ID: 12526171
    [No Abstract]   [Full Text] [Related]  

  • 6. Production of vesicular stomatitis virus G glycoprotein (VSV-G) pseudotyped retroviral vectors.
    Lo HL; Yee JK
    Curr Protoc Hum Genet; 2007 Jan; Chapter 12():Unit 12.7. PubMed ID: 18428407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stable expression of the ecotropic retrovirus receptor in amphotropic packaging cells facilitates the transfer of recombinant vectors and enhances the yield of retroviral particles.
    Gerstmayer B; Groner B; Wels W; Schnierle BS
    J Virol Methods; 1999 Aug; 81(1-2):71-5. PubMed ID: 10488763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retroviral vector capable of targeted gene transfer into cells expressing HIV envelope glycoprotein.
    Suzuki S; Shimada T
    Biochem Biophys Res Commun; 2000 May; 271(3):672-6. PubMed ID: 10814520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-performance liquid chromatographic total particles quantification of retroviral vectors pseudotyped with vesicular stomatitis virus-G glycoprotein.
    Transfiguracion J; Coelho H; Kamen A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 813(1-2):167-73. PubMed ID: 15556530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient Transduction of Zebrafish Melanoma Cell Lines and Embryos Using Lentiviral Vectors.
    Fazio M; Avagyan S; van Rooijen E; Mannherz W; Kaufman CK; Lobbardi R; Langenau DM; Zon LI
    Zebrafish; 2017 Aug; 14(4):379-382. PubMed ID: 28557653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting retroviral and lentiviral vectors.
    Sandrin V; Russell SJ; Cosset FL
    Curr Top Microbiol Immunol; 2003; 281():137-78. PubMed ID: 12932077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor-specific targeting mediated by the coexpression of a targeted murine leukemia virus envelope protein and a binding-defective influenza hemagglutinin protein.
    Lin AH; Kasahara N; Wu W; Stripecke R; Empig CL; Anderson WF; Cannon PM
    Hum Gene Ther; 2001 Mar; 12(4):323-32. PubMed ID: 11242525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting retrovirus entry.
    Cosset FL; Russell SJ
    Gene Ther; 1996 Nov; 3(11):946-56. PubMed ID: 8940634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphotropic retroviral vectors displaying hepatocyte growth factor-envelope fusion proteins improve transduction efficiency of primary hepatocytes.
    Nguyen TH; Pagès JC; Farge D; Briand P; Weber A
    Hum Gene Ther; 1998 Nov; 9(17):2469-79. PubMed ID: 9853514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Size-exclusion chromatography purification of high-titer vesicular stomatitis virus G glycoprotein-pseudotyped retrovectors for cell and gene therapy applications.
    Transfiguracion J; Jaalouk DE; Ghani K; Galipeau J; Kamen A
    Hum Gene Ther; 2003 Aug; 14(12):1139-53. PubMed ID: 12908966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Removal of envelope protein-free retroviral vectors by anion-exchange chromatography to improve product quality.
    Rodrigues T; Alves A; Lopes A; Carrondo MJ; Alves PM; Cruz PE
    J Sep Sci; 2008 Oct; 31(20):3509-18. PubMed ID: 18830959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a recombinant murine cytomegalovirus expressing vesicular stomatitis virus G protein to pseudotype retroviral vectors.
    Manning WC; Murphy JE; Jolly DJ; Mento SJ; Ralston RO
    J Virol Methods; 1998 Jul; 73(1):31-9. PubMed ID: 9705172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudotyped retroviral vectors for studies of human gene therapy.
    Friedmann T; Yee JK
    Nat Med; 1995 Mar; 1(3):275-7. PubMed ID: 7585046
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhanced retroviral transduction efficiency of pancreatic tumor cell lines using different envelope glycoproteins.
    Howard BD; Boenicke L; Schneider-Brachert W; Kalthoff H
    Ann N Y Acad Sci; 1999 Jun; 880():366-70. PubMed ID: 10415880
    [No Abstract]   [Full Text] [Related]  

  • 20. Rhesus monkey model for fetal gene transfer: studies with retroviral- based vector systems.
    Tarantal AF; O'Rourke JP; Case SS; Newbound GC; Li J; Lee CI; Baskin CR; Kohn DB; Bunnell BA
    Mol Ther; 2001 Feb; 3(2):128-38. PubMed ID: 11237669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.